Cargando…

New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China()

Detalles Bibliográficos
Autor principal:	Hu, Da-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627699/ https://www.ncbi.nlm.nih.gov/pubmed/29063058 http://dx.doi.org/10.1016/j.cdtm.2016.11.001

Ejemplares similares

Atherosclerotic Cardiovascular Disease: Risk Assessment, Prevention and Treatment Strategies
por: Jeras, Jernej, et al.
Publicado: (2022)

Editorial: The 2021 European Society of Cardiology (ESC) Guidelines on the Real-World Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)
por: Parums, Dinah V.
Publicado: (2021)

Updated guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists
por: Babadagli, Hazal E., et al.
Publicado: (2023)

Prevention and Treatment of Osteoporosis: Clinical Guidelines and New Evidence
por: Compston, Juliet
Publicado: (2000)

Preventing Atherosclerotic Cardiovascular Disease Using American College of Cardiology and American Heart Association Prevention Guidelines: Some Good News, But Caveats Remain
por: Stone, Neil J.
Publicado: (2016)

Management of Dyslipidemia in Secondary Prevention of Cardiovascular Disease: The Gap between Theory and Practice
por: Santangelo, Gloria, et al.
Publicado: (2022)

Time to consider an Asian guideline for management of dyslipidemia?
por: Yokote, Koutaro, et al.
Publicado: (2012)

Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs
por: Zodda, Donatella, et al.
Publicado: (2018)

Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease
por: Vesa, Cosmin Mihai, et al.
Publicado: (2023)

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
por: Kinoshita, Makoto, et al.
Publicado: (2018)

Dyslipidemia and Cardiovascular Disease: Current Knowledge, Existing Challenges, and New Opportunities for Management Strategies
por: Du, Zhiyong, et al.
Publicado: (2023)

Lifestyle management to prevent atherosclerotic cardiovascular disease: evidence and challenges
por: van Trier, T. J., et al.
Publicado: (2021)

Social Network Structure and Atherosclerotic Cardiovascular Disease
por: Nishi, Nobuo
Publicado: (2018)

Early Markers of Atherosclerotic Disease in Individuals with Excess Weight and Dyslipidemia
por: Menti, Eduardo, et al.
Publicado: (2016)

New Insights in Prevention and Treatment of Cardiovascular Disease
por: Di Raimondo, Domenico, et al.
Publicado: (2022)

Cholesterol and Atherosclerotic Cardiovascular Disease: A Lifelong Problem
por: Gidding, Samuel S., et al.
Publicado: (2019)

SIRT1 and Gender Differences in Atherosclerotic Cardiovascular Disease
por: Shimabukuro, Michio
Publicado: (2020)

Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?
por: Tanaka, Ana Cristina Sayuri
Publicado: (2018)

Carotid atherosclerotic disease
por: Sitrângulo, Cid José, et al.
Publicado: (2018)

A Risk Prediction Model of Atherosclerotic Cardiovascular Disease in Japan
por: Saito, Isao
Publicado: (2022)

Obstructive sleep apnea combined dyslipidemia render additive effect on increasing atherosclerotic cardiovascular diseases prevalence
por: Cao, Zhiyong, et al.
Publicado: (2016)

Childhood Dyslipidemia and Carotid Atherosclerotic Plaque in Adulthood: The Cardiovascular Risk in Young Finns Study
por: Koskinen, Juhani S., et al.
Publicado: (2023)

Implication of new atherosclerotic carotid plaques in the cardiovascular outcome of patients with rheumatoid arthritis
por: González-Gay, Miguel A, et al.
Publicado: (2012)

Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore
por: Setia, Sajita, et al.
Publicado: (2015)

A Checklist Approach for Enhanced Outpatient Guideline-Directed Management in the Secondary Prevention of Atherosclerotic Cardiovascular Disease
por: Taha, Mohamad B., et al.
Publicado: (2021)

The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings
por: Athyros, Vasilios G., et al.
Publicado: (2012)

Cardiovascular Imaging for the Primary Prevention of Atherosclerotic Cardiovascular Disease Events
por: Weber, Lauren A., et al.
Publicado: (2015)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
por: Wang, Kexin, et al.
Publicado: (2022)

American Association of Clinical Endocrinologists/American College of Endocrinology Management of Dyslipidemia and Prevention of Cardiovascular Disease Clinical Practice Guidelines
por: Jellinger, Paul S.
Publicado: (2018)

Is Lipoprotein(a) the Most Important Predictor of Residual Atherosclerotic Cardiovascular Disease Risk?
por: Wong, Nathan D.
Publicado: (2022)

Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
por: Gourdy, Pierre, et al.
Publicado: (2023)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
por: Bi, Lei, et al.
Publicado: (2022)

Adherence to Guideline Medication Recommendations to Prevent Atherosclerotic Cardiovascular Disease Progression Among Adults With Prior Myocardial Infarction
por: Arnold, Suzanne V., et al.
Publicado: (2020)

Mass prevention and treatment: Fundamental strategy for chronic disease control and prevention
por: Hu, Da-Yi
Publicado: (2016)

Magnesium for the prevention and treatment of cardiovascular disease
por: DiNicolantonio, James J, et al.
Publicado: (2018)

2018 Guidelines for the management of dyslipidemia
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

L-Arginine, Nitric Oxide, and Endothelial Dysfunction Underlying Atherosclerotic Cardiovascular Disease (ASCVD)
por: Shimabukuro, Michio
Publicado: (2023)

Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can “Thrombin Pathway” Be a New Target for Therapy?
por: Kim, Hyun Kuk, et al.
Publicado: (2020)

Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
por: Albosta, Michael S, et al.
Publicado: (2023)

Primary Prevention of Colorectal Neoplasias: Ample Evidence, Lack of Guidelines
por: Seretis, Fotios, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_86bl2hu7jhlklvfcaropsjucc6